All lobbying filings

THE MCMANUS GROUP

Lobbying for LARGE UROLOGY GROUP PRACTICE ASSOCIATION · Client is a membership association for large physician group practices.

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 20, 2026

Income

$90,000

What the client paid this registrant for the period.

Client based in

Illinois

Official filing document

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 3

Taxation/Internal Revenue Code

Issues related to the Tax Exempt Hospital Transparency Act (H.R. 9504).

Medicare/Medicaid

Issues related to access and physician reimbursement under Medicare Part B, including H.R. 879 - Medicare Patient Access and Practice Stabilization Act; H.R. 2474 - Strengthening Medicare for Patients and Providers Act; S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025 Implementation of provisions included in Subtitle B of PL.117-169-Inflation Reduction Act of 2022. H.R. 2484- Seniors' Access to Critical Medications Act of 2025. Issues related to prior authorization. H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act Issues related to stark regulation of in office dispensing of Part D drugs. Issues related to the Provider Reimbursement Stability Act of 2026 (H.R.8163). Issues related to the Patients First Act of 2026 (H.R.9693)

Health Issues

Issues related to reforming and increasing transparency within the 340B Drug Pricing Program.

Bills named in this filing 8

H.R. 9504
Tax Exempt Hospital Transparency Act
H.R. 879
Medicare Patient Access and Practice Stabilization Act of 2025
H.R. 2474
Strengthening Medicare for Patients and Providers Act
S. 1640
Medicare Patient Access and Practice Stabilization Act of 2025
H.R. 2484
Seniors’ Access to Critical Medications Act of 2025
H.R. 4299
Protecting Patient Access to Cancer and Complex Therapies Act
H.R. 8163
Provider Reimbursement Stability Act of 2026
H.R. 9693
Patients First Act of 2026

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.